XML 31 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business segment information (Tables)
6 Months Ended
Jun. 30, 2012
Business segment information  
Schedule of external net sales for continuing operations by GBU

 

 

 

 

External Net Sales by GBU

 

 

 

Three Months Ended June 30,

 

(US$ in thousands)

 

2012

 

2011

 

Reported
Growth

 

Constant
Currency
Growth

 

Spine

 

 

 

 

 

 

 

 

 

Spine Repair Implants and Regenerative Biologics

 

$

38,501

 

$

36,882

 

4

%

4

%

Spine Regenerative Stimulation

 

43,294

 

39,660

 

9

%

9

%

 

 

 

 

 

 

 

 

 

 

Total Spine

 

81,795

 

76,542

 

7

%

7

%

 

 

 

 

 

 

 

 

 

 

Orthopedics

 

37,697

 

40,128

 

(6

)%

2

%

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

119,492

 

$

116,670

 

2

%

5

%

 

 

 

External Net Sales by GBU

 

 

 

Six Months Ended June 30,

 

(US$ in thousands)

 

2012

 

2011

 

Reported
Growth

 

Constant
Currency
Growth

 

Spine

 

 

 

 

 

 

 

 

 

Spine Repair Implants and Regenerative Biologics

 

$

74,258

 

$

70,839

 

5

%

5

%

Spine Regenerative Stimulation

 

82,565

 

78,278

 

5

%

5

%

 

 

 

 

 

 

 

 

 

 

Total Spine

 

156,823

 

149,117

 

5

%

5

%

 

 

 

 

 

 

 

 

 

 

Orthopedics

 

78,711

 

80,614

 

(2

)%

3

%

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

235,534

 

$

229,731

 

3

%

4

%

Operating income (loss) by GBU

 

 

Operating Income (Loss) by GBU

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

(US$ in thousands)

 

2012

 

2011

 

2012

 

2011

 

Spine (1)

 

$

21,029

 

$

22,292

 

$

42,594

 

$

5,866

 

Orthopedics (2)

 

4,093

 

4,972

 

9,073

 

1,340

 

Corporate (3)

 

(4,557

)

(7,868

)

(8,671

)

(15,307

)

 

 

 

 

 

 

 

 

 

 

Total

 

$

20,565

 

$

19,396

 

$

42,996

 

$

(8,101

)

 

 

(1)                 For the six months ended June 30, 2012 and 2011, the operating income for the Spine GBU included $1.2 million and $36.5 million, respectively, of expenses in connection with charges related to U.S. Government resolutions. For the six months ended June 30, 2012, the operating income for the Spine GBU included a $3.1 million charge for an arbitration resolution related to a 2008 co-development agreement.

(2)                 For the six months ended June 30, 2012 and 2011, the operating income for the Orthopedics GBU included $0.2 million and $6.5 million, respectively, of expenses in connection with charges related to U.S. Government resolutions.

(3)                 For the six months ended June 30, 2011, the operating loss for the Corporate GBU included $3 million of expenses in connection with charges related to U.S. Government resolutions. For the three and six months ended June 30, 2011, the operating loss for the Corporate GBU included $3.2 million of senior management succession charges.